These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 15740097)

  • 1. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering non-natural inhibitor sensitivity in protein tyrosine phosphatase H1.
    Blair ER; Hoffman HE; Bishop AC
    Bioorg Med Chem; 2006 Jan; 14(2):464-71. PubMed ID: 16182535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta).
    Drake PG; Peters GH; Andersen HS; Hendriks W; Møller NP
    Biochem J; 2003 Jul; 373(Pt 2):393-401. PubMed ID: 12697028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
    Bishop AC; Blair ER
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
    Stuible M; Zhao L; Aubry I; Schmidt-Arras D; Böhmer FD; Li CJ; Tremblay ML
    Chembiochem; 2007 Jan; 8(2):179-86. PubMed ID: 17191286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
    Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
    Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors.
    Ottanà R; Maccari R; Ciurleo R; Paoli P; Jacomelli M; Manao G; Camici G; Laggner C; Langer T
    Bioorg Med Chem; 2009 Mar; 17(5):1928-37. PubMed ID: 19217304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
    Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
    Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
    Schmidt MF; Groves MR; Rademann J
    Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered inhibitor sensitivity in the WPD loop of a protein tyrosine phosphatase.
    Zhang XY; Bishop AC
    Biochemistry; 2008 Apr; 47(15):4491-500. PubMed ID: 18358001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
    Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
    Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the molecular basis for potent and selective protein-tyrosine phosphatase 1B inhibition.
    Guo XL; Shen K; Wang F; Lawrence DS; Zhang ZY
    J Biol Chem; 2002 Oct; 277(43):41014-22. PubMed ID: 12193602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
    Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
    Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of catalytically inactive mutants of protein tyrosine phosphatases (PTPs) in a phosphopeptide microarray.
    Sun H; Tan LP; Gao L; Yao SQ
    Chem Commun (Camb); 2009 Feb; (6):677-9. PubMed ID: 19322419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.